Brazil recorded 184,311 cases of Covid-19 and 493 deaths from the disease in the last 24 hours. The numbers were released by the Ministry of Health this Friday (4).
As a result, Brazil recorded more cases of Covid-19 in 2022 than throughout the second half of 2021. There are 3,988,310 infections in these first 35 days of the year against 3,730,380 between July 1 and December 31 of the year. last year.
In all, since the beginning of the pandemic, the country has already accumulated 26,275,831 cases of Covid-19 and 630,494 deaths from the disease.
The moving average of cases is at 177,289, while that of deaths is at 659. The moving averages take into account the last seven days and are used to avoid possible distortions caused by underreporting on weekends.
Hospitalizations of children in ICUs increased almost 10 times in RJ in December
The hospitalization rate of children up to 12 years old with Covid-19 in ICUs in the state of Rio de Janeiro grew 850% in January, when compared to December last year, according to the State Health Department. six to 12 years were admitted to intensive care beds. In the first month of 2022, the number jumped to 57. Read more.
Belo Horizonte opposes MP and maintains suspension of face-to-face classes for children
The city of Belo Horizonte informed this Friday (4) that it will contradict the recommendation of the Public Ministry of Minas Gerais (MPMG) and will not determine the immediate return of face-to-face classes in all age groups in the capital of Minas Gerais.
According to the municipality, face-to-face classes for children aged 5 to 11 will only start on February 14th. The announcement of the suspension of face-to-face activities for this group was made by Mayor Alexandre Kalil on January 26th. The decision was criticized by experts heard by the CNN. Read more.
Anvisa revokes authorization for antibody cocktail against Covid-19
The Collegiate Board of Anvisa revoked, this Friday (2), the authorization it had granted to the emergency use of an antibody cocktail (banlanivimab and etesevimab) for the treatment of Covid-19, from the company Eli Lilly.
The cocktail had received authorization from Anvisa for emergency use on May 13, 2021. Read more.
Source: CNN Brasil
